A systematic assessment of benefits and risks to guide breast cancer screening decisions

JAMA

Volumn 311, Issue 13, 2014, Pages 1327-1335

  Pace, Lydia E ^a   Keating, Nancy L ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; DECISION MAKING; DIAGNOSTIC ERROR; EARLY DIAGNOSIS; FALSE POSITIVE RESULT; HEALTH INSURANCE; HUMAN; MAMMOGRAPHY; MEDICAL DECISION MAKING; META ANALYSIS (TOPIC); OVERDIAGNOSIS; PATIENT DECISION MAKING; PERSONALIZED MEDICINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; DECISION MAKING; EARLY DETECTION OF CANCER; EVIDENCE-BASED MEDICINE; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MAMMOGRAPHY; META-ANALYSIS AS TOPIC; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REVIEW LITERATURE AS TOPIC; RISK FACTORS;

EID: 84897511975     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.1398     Document Type: Review

References (86)

1. Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review (CSR), 1975-2010. Surveillance, Epidemiology, and End Results Program website. http://seer.cancer.gov/csr/1975-2010/. 2013. Accessed January 17, 2014.
2. US Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716-726.
3. National Health Service (NHS) Breast Cancer Screening Programme. What Does the NHS Breast Screening Programme Do? NHS Breast Cancer Screening Programme website. http://www.cancerscreening.nhs.uk/breastscreen/screening- programme.html. Accessed January 21, 2014.
4. Norwegian Breast Cancer Screening Programme. Cancer Registry of Norway website. http://www.kreftregisteret.no/en/Cancer-prevention/Breast-Cancer- Screening-Programme/. 2012. Accessed January 21, 2014.
5. American Cancer Society. Press Release: American Cancer Society Responds to Changes to USPSTF Mammography Guidelines. American Cancer Society website. http://pressroom.cancer.org/index.php?s=43&item=201. 2009. Accessed October 7, 2012.
6. National Cancer Institute. Mammograms. National Cancer Institute website. http://www.cancer.gov/cancertopics/factsheet/detection/mammograms. 2012. Accessed October 11, 2013.
7. Pace LE, He Y, Keating NL. Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer. 2013;119(14):2518-2523.
8. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L; Trial Management Group. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet. 2006;368(9552):2053-2060. (Pubitemid 44855105)
9. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L; U.S. Preventive Services Task Force. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151(10):727-737.
10. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up: a randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med. 2002;137(5, part 1):305-312. (Pubitemid 34977131)
11. Tabár L, Vitak B, Chen TH, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011;260(3):658-663.
12. Habbema JD, van Oortmarssen GJ, van Putten DJ, Lubbe JT, van der Maas PJ. Age-specific reduction in breast cancer mortality by screening: an analysis of the results of the Health Insurance Plan of Greater New York study. J Natl Cancer Inst. 1986;77(2):317-320. (Pubitemid 16039379)
13. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359(9310):909-919. (Pubitemid 34246378)
14. Bjurstam N, Björneld L, Warwick J, et al. The Gothenburg Breast Screening Trial. Cancer. 2003;97(10):2387-2396. (Pubitemid 36542476)
15. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst. 2000;92(18):1490-1499.
16. National Cancer Institute (NCI). DevCan - Probability of Developing or Dying of Cancer. NCI Surveillance Research website. http://surveillance.cancer. gov/devcan. Accessed March 11, 2014.
17. Welch HG, Passow HJ. Quantifying the benefits and harms of screening mammography. JAMA Intern Med. 2014;174(3):448-454.
18. National Cancer Institute (NCI). SEER*Stat software version 8.0.4. NCI website. http://seer.cancer.gov/seerstat. Accessed March 11, 2014.
19. National Center for Health Statistics. Health, United States, 2012: With Special Feature on Emergency Care. Hyattsville, MD: National Center for Health Statistics; 2013.
20. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ. 2006;332(7543):689-692.
21. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367(21):1998-2005.
22. Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med. 2011;155(8):481-492.
23. Braithwaite D, Zhu W, Hubbard RA, et al; Breast Cancer Surveillance Consortium. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst. 2013;105(5):334-341.
24. Alexander FE, Anderson TJ, Brown HK, et al. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet. 1999;353(9168):1903-1908. (Pubitemid 29255701)
25. Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013;6:CD001877.
26. Fitzpatrick-Lewis D, Hodgson N, Ciliska D, Peirson L, Gauld M, Liu YY. Breast Cancer Screening. Canadian Task Force on Preventive Health Care website. http://canadiantaskforce.ca/wp-content/uploads/2012/09/Systematic-review.pdf? 447f29. 2011. Accessed October 12, 2013.
27. Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ. 2014;348:g366.
28. Bastardis-Zakas K, Iatrakis G, Navrozoglou I, et al. Maximizing the benefits of screening mammography for women 40-49 years old. Clin Exp Obstet Gynecol. 2010;37(4):278-282.
29. Magnus MC, Ping M, Shen MM, Bourgeois J, Magnus JH. Effectiveness of mammography screening in reducing breast cancer mortality in women aged 39-49 years: a meta-analysis. J Womens Health (Larchmt). 2011;20(6):845-852.
30. Hanoch Y. Improving doctor-patient understanding of probability in communicating cancer-screening test findings. J Health Commun. 2004;9(4):327-335. (Pubitemid 39107941)
31. Barrett B, McKenna P. Communicating benefits and risks of screening for prostate, colon, and breast cancer. Fam Med. 2011;43(4):248-253.
32. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med. 1998;338(16):1089-1096. (Pubitemid 28227478)
33. Mandelblatt JS, Cronin KA, Bailey S, et al; Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151(10):738-747.
34. Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med. 2007;146(7):502-510. (Pubitemid 351650559)
35. Hafslund B, Espehaug B, Nortvedt MW. Effects of false-positive results in a breast screening program on anxiety, depression and health-related quality of life. Cancer Nurs. 2012;35(5):26-34.
36. Espasa R, Murta-Nascimento C, Bayés R, et al. The psychological impact of a false-positive screening mammogram in Barcelona. J Cancer Educ. 2012;27(4):780-785.
37. van der Steeg AF, Keyzer-Dekker CM, De Vries J, Roukema JA. Effect of abnormal screening mammogram on quality of life. Br J Surg. 2011;98(4):537-542.
38. Brodersen J, Siersma VD. Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med. 2013;11(2):106-115.
39. Seigneurin A, Exbrayat C, Labarère J, Delafosse P, Poncet F, Colonna M. Association of diagnostic work-up with subsequent attendance in a breast cancer screening program for false-positive cases. Breast Cancer Res Treat. 2011;127(1):221-228.
40. Alamo-Junquera D, Murta-Nascimento C, Macià F, et al; Cumulative False-Positive Risk Group. Effect of false-positive results on reattendance at breast cancer screening programmes in Spain. Eur J Public Health. 2012;22(3):404-408.
41. Burman ML, Taplin SH, Herta DF, Elmore JG. Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization. Ann Intern Med. 1999;131(1):1-6. (Pubitemid 29310010)
42. Setz-Pels W, Duijm LE, Coebergh JW, Rutten M, Nederend J, Voogd AC. Re-attendance after false-positive screening mammography: a population-based study in the Netherlands. Br J Cancer. 2013;109(8):2044-2050.
43. Etzioni R, Gulati R, Mallinger L, Mandelblatt J. Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening. Ann Intern Med. 2013;158(11):831-838.
44. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380(9855):1778- 1786.
45. Marmot MG. Sorting through the arguments on breast screening. JAMA. 2013;309(24):2553-2554.
46. Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108(11):2205-2240.
47. Gøtzsche PC. Ramifications of screening for breast cancer: overdiagnosis in the Malmö trial was considerably underestimated. BMJ. 2006;332(7543):727. (Pubitemid 44365698)
48. Paci E; EUROSCREEN Working Group. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. J Med Screen. 2012;19(suppl 1):5-13.
49. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ. 2009;339:b2587.
50. Puliti D, Duffy SW, Miccinesi G, et al; EUROSCREEN Working Group. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen. 2012;19(suppl 1):42-56.
51. Amir E, Freedman OC, Seruga B, Evans DG. Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst. 2010;102(10):680-691.
52. Cummings SR, Tice JA, Bauer S, et al. Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst. 2009;101(6):384-398.
53. Gail M, Rimer B. Risk-based recommendations for mammographic screening for women in their forties. J Clin Oncol. 1998;16(9):3105-3114. (Pubitemid 28417433)
54. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879-1886. (Pubitemid 20026073)
55. Gail MH, Costantino JP. Validating and improving models for projecting the absolute risk of breast cancer. J Natl Cancer Inst. 2001;93(5):334-335. (Pubitemid 32229370)
56. Barlow WE, White E, Ballard-Barbash R, et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst. 2006;98(17):1204-1214. (Pubitemid 44390991)
57. Gail MH, Costantino JP, Pee D, et al. Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst. 2007;99(23):1782-1792. (Pubitemid 351767204)
58. Chen J, Pee D, Ayyagari R, et al. Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst. 2006;98(17):1215-1226. (Pubitemid 44390992)
59. Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med. 2008;148(5):337-347. (Pubitemid 351665464)
60. Nelson HD, Zakher B, Cantor A, et al. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med. 2012;156(9):635-648.
61. Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med. 2011;155(1):10-20.
62. Ayer T, Alagoz O, Stout NKOR. Forum - a POMDP approach to personalize mammography screening decisions. Oper Res. 2012;60(5):1019-1034.
63. van Ravesteyn NT, Miglioretti DL, Stout NK, et al. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med. 2012;156(9):609-617.
64. Kerlikowske K, Zhu W, Hubbard RA, et al; Breast Cancer Surveillance Consortium. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med. 2013;173(9):807-816.
65. Nekhlyudov L, Braddock CH III. An approach to enhance communication about screening mammography in primary care. J Womens Health (Larchmt). 2009;18(9):1403-1412.
66. Braddock CH III, Edwards KA, Hasenberg NM, Laidley TL, Levinson W. Informed decision making in outpatient practice: time to get back to basics. JAMA. 1999;282(24):2313-2320. (Pubitemid 30013062)
67. Champion V, Maraj M, Hui S, et al. Comparison of tailored interventions to increase mammography screening in nonadherent older women. Prev Med. 2003;36(2):150-158. (Pubitemid 36268749)
68. Champion V, Skinner CS, Hui S, et al. The effect of telephone versus print tailoring for mammography adherence. Patient Educ Couns. 2007;65(3):416-423. (Pubitemid 46241783)
69. Stoddard AM, Fox SA, Costanza ME, et al NCI Breast Screening Consortium. Effectiveness of telephone counseling for mammography: results from five randomized trials. Prev Med. 2002;34(1):90-99. (Pubitemid 34971528)
70. Yabroff KR, O'Malley A, Mangan P, Mandelblatt J. Inreach and outreach interventions to improve mammography use. J Am Med Womens Assoc. 2001;56(4):166-173.
71. Jibaja-Weiss ML, Volk RJ, Kingery P, Smith QW, Holcomb JD. Tailored messages for breast and cervical cancer screening of low-income and minority women using medical records data. Patient Educ Couns. 2003;50(2):123-132. (Pubitemid 36627421)
72. Lipkus IM, Biradavolu M, Fenn K, Keller P, Rimer BK. Informing women about their breast cancer risks: truth and consequences. Health Commun. 2001;13(2):205-226. (Pubitemid 33602875)
73. Rimer BK, Halabi S, Sugg Skinner C, et al. Effects of a mammography decision-making intervention at 12 and 24 months. Am J Prev Med. 2002;22(4):247-257. (Pubitemid 34436891)
74. Albada A, Ausems MG, Bensing JM, van Dulmen S. Tailored information about cancer risk and screening: a systematic review. Patient Educ Couns. 2009;77(2):155-171.
75. Schwartz MD, Rimer BK, Daly M, Sands C, Lerman C. A randomized trial of breast cancer risk counseling: the impact on self-reported mammography use. Am J Public Health. 1999;89(6):924-926. (Pubitemid 29282718)
76. Edwards AG, Naik G, Ahmed H, et al. Personalised risk communication for informed decision making about taking screening tests. Cochrane Database Syst Rev. 2013;2:CD001865.
77. Stacey D, Bennett CL, Barry MJ, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2011;(10):CD001431.
78. Mathieu E, Barratt A, Davey HM, McGeechan K, Howard K, Houssami N. Informed choice in mammography screening: a randomized trial of a decision aid for 70-year-old women. Arch Intern Med. 2007;167(19):2039-2046. (Pubitemid 350036702)
79. Schonberg MA, Hamel MB, Davis RB, et al. Development and evaluation of a decision aid on mammography screening for women 75 years and older. JAMA Intern Med. 2014;174(3):417-424.
80. Mathieu E, Barratt AL, McGeechan K, Davey HM, Howard K, Houssami N. Helping women make choices about mammography screening: an online randomized trial of a decision aid for 40-year-old women. Patient Educ Couns. 2010;81(1):63-72.
81. Canadian Task Force on Preventive Health. Screening for Breast Cancer: Summary of Recommendations for Clinicians and Policy-makers. Canadian Task Force on Preventive Health website. http://canadiantaskforce.ca/guidelines/2011- breast-cancer/. Accessed January 21, 2014.
82. Arterburn D, Wellman R, Westbrook E, et al. Introducing decision aids at Group Health was linked to sharply lower hip and knee surgery rates and costs. Health Aff (Millwood). 2012;31(9):2094-2104.
83. Hersch J, Jansen J, Barratt A, et al. Women's views on overdiagnosis in breast cancer screening: a qualitative study. BMJ. 2013;346:f158.
84. The Patient Protection and Affordable Care Act 2010.
85. Welch HG. Breast cancer screenings: what we still don't know. New York Times. December 29, 2013:Opinion.
86. Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA. 2009;302(15):1685-1692.